BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 3881978)

  • 1. Acute and chronic actions of bradykinin on renal function and arterial pressure.
    Granger JP; Hall JE
    Am J Physiol; 1985 Jan; 248(1 Pt 2):F87-92. PubMed ID: 3881978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of B1- and B2-kinin receptors in the renal tubular and hemodynamic response to bradykinin.
    Lortie M; Regoli D; Rhaleb NE; Plante GE
    Am J Physiol; 1992 Jan; 262(1 Pt 2):R72-6. PubMed ID: 1310238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that intrarenal bradykinin plays a role in regulation of renal function.
    Siragy HM
    Am J Physiol; 1993 Oct; 265(4 Pt 1):E648-54. PubMed ID: 8238340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among endotoxemia, arterial pressure, and renal function in dogs.
    O'Hair DP; Adams MB; Tunberg TC; Osborn JL
    Circ Shock; 1989 Mar; 27(3):199-210. PubMed ID: 2650915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
    Biggi A; Musiari L; Iori M; De Iaco G; Magnani G; Pelloni I; Pinelli S; PelĂ  GM; Novarini A; Cabassi A; Montanari A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):911-6. PubMed ID: 20504911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intrarenal angiotensin II infusion on the renal escape from mineralocorticoid.
    Opgenorth TJ; Granger JP; Chakravarthy A; Knox FG; Romero JC
    Am J Physiol; 1985 Dec; 249(6 Pt 2):F813-8. PubMed ID: 4073265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal infusion of bradykinin elicits a pressor response in conscious rats via a B2-receptor mechanism.
    Hoagland KM; Maddox DA; Martin DS
    Can J Physiol Pharmacol; 1999 Aug; 77(8):563-70. PubMed ID: 10543719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal haemodynamic and excretory responses to bradykinin in anaesthetized dogs.
    Matsumura Y; Tadano K; Yamasaki T
    Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):645-50. PubMed ID: 10474781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bradykinin on renal function in dogs treated with indomethacin or propranolol.
    Yun JC; Gill JR; Bartter FC; Kelly GD; Keiser HR
    Ren Physiol; 1982; 5(1):31-43. PubMed ID: 7079557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bradykinin and papaverine on renal autoregulation and renin release in the anaesthetized dog.
    Bugge JF; Stokke ES; Kiil F
    Acta Physiol Scand; 1991 Dec; 143(4):431-7. PubMed ID: 1815477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics in response to a kinin analogue antagonist.
    Beierwaltes WH; Carretero OA; Scicli AG
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F408-14. PubMed ID: 3414801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs.
    Hall JE; Granger JP
    Am J Physiol; 1986 Jan; 250(1 Pt 2):F32-9. PubMed ID: 3942225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in renal vascular sensitivity and arterial pressure associated with sodium intake during long-term intrarenal norepinephrine infusion in dogs.
    Cowley AW; Lohmeier TE
    Hypertension; 1979; 1(6):549-58. PubMed ID: 396248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic and vasodilating activities of intrarenally administered atriopeptin II, substance P and bradykinin in the dog.
    DeFelice AF; Brousseau A
    J Pharmacol Exp Ther; 1988 Jul; 246(1):183-8. PubMed ID: 2455790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of sustained hypertension by chronic intrarenal norepinephrine infusion in conscious dogs.
    Katholi RE; Carey RM; Ayers CR; Vaughan ED; Yancey MR; Morton CL
    Circ Res; 1977 May; 40(5 Suppl 1):I118-26. PubMed ID: 870220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of intrarenal NO stimulates renin secretion through a macula densa-mediated mechanism.
    Schnackenberg CG; Tabor BL; Strong MH; Granger JP
    Am J Physiol; 1997 Mar; 272(3 Pt 2):R879-86. PubMed ID: 9087651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
    Levens N; Beil M; Jarvis M
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal sensitivity to angiotensin II in the conscious dog.
    Siragy HM; Lamb NE; Woodson JF; Ragsdale NV; Rose CE; Peach MJ; Carey RM
    Endocrinology; 1987 Apr; 120(4):1272-8. PubMed ID: 3549257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.